Skip to content

GEOVAX LABS, INC.: 10-Q filed 2025-07-28

What GEOVAX LABS, INC. reported in its quarterly report filed 2025-07-28 (fiscal Q2 2025): 31 published measures, 86 facts as tagged in accession 0001437749-25-023651.

This filing

Form
10-Q (quarterly report)
Filed
2025-07-28
Fiscal period
fiscal Q2 2025
Accession
0001437749-25-023651 on SEC EDGAR

Values are as tagged in this filing. A later filing can restate them; each measure links to its history page, which shows the latest-filed value per period. All GEOVAX LABS, INC. filings.

Reported measures

Total assets

Resources recognized on the balance sheet. Book assets are not the market value of the business.

PeriodValueUnitDays
At 2025-06-305,350,420USD
At 2024-12-318,155,867USD

Stockholders equity

The reported residual interest after liabilities. It is an accounting amount, not market capitalization.

PeriodValueUnitDays
At 2025-06-302,821,196USD
At 2025-03-317,898,030USD
At 2024-12-315,048,535USD
At 2024-06-30-2,309,226USD
At 2024-03-3154,275USD
At 2023-12-315,763,338USD

Cash and cash equivalents

Cash and qualifying short-term liquid investments under the filer’s accounting policy. Restricted cash and longer-term investments may be reported separately.

PeriodValueUnitDays
At 2025-06-303,093,862USD
At 2024-12-315,506,941USD

Net income or loss

Reported profit or loss for the period. Check the filing for attribution, exceptional items and discontinued operations before comparing companies.

PeriodValueUnitDays
2025-04-01 to 2025-06-30-5,369,783USD91
2025-01-01 to 2025-06-30-10,727,434USD181
2025-01-01 to 2025-03-31-5,357,651USD90
2024-04-01 to 2024-06-30-5,064,042USD91
2024-01-01 to 2024-06-30-10,914,174USD182
2024-01-01 to 2024-03-31-5,850,132USD91

Operating cash flow

Cash generated or used by operating activities. Working-capital timing can make this differ substantially from reported income.

PeriodValueUnitDays
2025-01-01 to 2025-06-30-10,300,078USD181
2024-01-01 to 2024-06-30-7,624,778USD182

Capital expenditure payments

Cash payments to acquire property, plant and equipment. This taxonomy concept does not capture every form of investment or acquisition.

PeriodValueUnitDays
2025-01-01 to 2025-06-3027,612USD181
2024-01-01 to 2024-06-300USD182

Financing cash flow

Net cash from financing activities, including borrowing, repayments and transactions with owners. A positive amount does not establish operating profitability.

PeriodValueUnitDays
2025-01-01 to 2025-06-307,914,611USD181
2024-01-01 to 2024-06-302,733,901USD182

Investing cash flow

Net cash from investing activities, including asset purchases, disposals and investment transactions. This differs from capital expenditure payments alone.

PeriodValueUnitDays
2025-01-01 to 2025-06-30-27,612USD181
2024-01-01 to 2024-06-300USD182

Retained earnings or deficit

Accumulated undistributed earnings or deficit at the reporting date. This balance is not cash available for distribution.

PeriodValueUnitDays
At 2025-06-30-140,083,515USD
At 2024-12-31-129,356,081USD

Basic weighted-average shares

Time-weighted shares used for basic earnings per share. This denominator differs from shares outstanding at a single reporting date.

PeriodValueUnitDays
2025-04-01 to 2025-06-3015,359,220shares91
2025-01-01 to 2025-06-3013,597,293shares181
2024-04-01 to 2024-06-302,539,878shares91
2024-01-01 to 2024-06-302,334,464shares182

Basic earnings per share

Reported earnings or loss per basic common share or unit. Inspect attribution, share classes and restatements before comparing periods. This is not a market return.

PeriodValueUnitDays
2025-04-01 to 2025-06-30-0.35USD/shares91
2025-01-01 to 2025-06-30-0.79USD/shares181
2024-04-01 to 2024-06-30-1.99USD/shares91
2024-01-01 to 2024-06-30-4.68USD/shares182

Income tax expense or benefit

Current and deferred income tax expense or benefit for continuing operations. This accounting expense differs from cash taxes paid.

PeriodValueUnitDays
2025-01-01 to 2025-06-300USD181
2024-01-01 to 2024-06-300USD182

Net property, plant and equipment

Carrying amount of property, plant and equipment after accumulated depreciation, depletion and amortization. It is not replacement cost or market value.

PeriodValueUnitDays
At 2025-06-30143,862USD
At 2024-12-31149,974USD

Share-based compensation expense

Reported noncash expense for share-based payment arrangements. Noncash treatment does not mean the awards have no economic cost to shareholders.

PeriodValueUnitDays
2025-01-01 to 2025-06-30585,484USD181
2024-01-01 to 2024-06-30259,376USD182

Operating income or loss

Operating revenue less operating expenses for the reporting period. It excludes items outside the reported operating result and is not free cash flow.

PeriodValueUnitDays
2025-04-01 to 2025-06-30-5,418,906USD91
2025-01-01 to 2025-06-30-10,824,076USD181
2024-04-01 to 2024-06-30-5,062,221USD91
2024-01-01 to 2024-06-30-10,945,302USD182

Current assets

Assets classified as current under the normal operating cycle or one-year boundary. Not all current assets can be converted immediately into cash.

PeriodValueUnitDays
At 2025-06-305,135,548USD
At 2024-12-317,934,883USD

Current liabilities

Obligations classified as current under the operating-cycle or one-year boundary. The balance includes more than short-term borrowing.

PeriodValueUnitDays
At 2025-06-302,529,224USD
At 2024-12-313,107,332USD

Current accounts payable

Current amounts owed to suppliers for goods and services received. This is one component of current liabilities, not all accrued obligations.

PeriodValueUnitDays
At 2025-06-301,830,148USD
At 2024-12-311,849,760USD

Net current accounts receivable

Current customer receivables after the allowance for credit loss. The balance is not cash collected or a guarantee of collection.

PeriodValueUnitDays
At 2025-06-30532,771USD
At 2024-12-31659,409USD

Operating expenses

Recurring operating costs under this accounting concept, generally excluding production costs included in cost of sales. Check filing presentation before combining expense subtotals.

PeriodValueUnitDays
2025-04-01 to 2025-06-306,271,188USD91
2025-01-01 to 2025-06-3013,313,221USD181
2024-04-01 to 2024-06-305,362,898USD91
2024-01-01 to 2024-06-3011,245,979USD182

Research and development expense

Research and development costs recognized as expense. Capitalization policies and acquired projects can make this differ from total cash invested in development.

PeriodValueUnitDays
2025-04-01 to 2025-06-304,728,998USD91
2025-01-01 to 2025-06-3010,083,586USD181
2024-04-01 to 2024-06-304,276,868USD91
2024-01-01 to 2024-06-308,702,596USD182

Common shares outstanding

Common shares outstanding at the reporting date. This point-in-time count differs from the weighted-average shares used for earnings per share and can exclude other share classes.

PeriodValueUnitDays
At 2025-06-3015,924,593shares
At 2024-12-3110,536,875shares

Gross property, plant and equipment

Cost of property, plant and equipment before accumulated depreciation. Historical cost does not indicate current value or replacement cost.

PeriodValueUnitDays
At 2025-06-30938,628USD
At 2024-12-31911,016USD

Accumulated depreciation on property, plant and equipment

Cumulative depreciation, depletion and amortization recorded against property, plant and equipment. It measures cost allocation to date, not physical wear or market value.

PeriodValueUnitDays
At 2025-06-30794,766USD
At 2024-12-31761,042USD

Other noncurrent assets

Noncurrent assets the filer does not present separately. The composition differs by filer and is described only in the filing.

PeriodValueUnitDays
At 2025-06-3071,010USD
At 2024-12-3171,010USD

Accrued current liabilities

Current obligations accrued for goods and services received but not yet invoiced or paid. This is one component of current liabilities, not all short-term obligations.

PeriodValueUnitDays
At 2025-06-30699,076USD
At 2024-12-311,257,572USD

Prepaid expenses and other current assets

Prepayments and other current assets grouped under this concept. The balance is not cash and its composition differs by filer.

PeriodValueUnitDays
At 2025-06-301,508,915USD
At 2024-12-311,768,533USD

General and administrative expense

General and administrative costs reported under this concept, separate from selling expense. Filers group overhead differently, so compare presentation before comparing companies.

PeriodValueUnitDays
2025-04-01 to 2025-06-301,542,190USD91
2025-01-01 to 2025-06-303,229,635USD181
2024-04-01 to 2024-06-301,086,030USD91
2024-01-01 to 2024-06-302,543,383USD182

Depreciation, depletion and amortization

Combined depreciation, depletion and amortization for the period. A noncash allocation of asset cost, not a measure of maintenance spending.

PeriodValueUnitDays
2025-01-01 to 2025-06-3033,724USD181
2024-01-01 to 2024-06-3043,319USD182

Nonoperating interest expense

Interest expense presented outside operating results. It differs from total interest expense when some borrowing cost is classified as operating or capitalized.

PeriodValueUnitDays
2025-04-01 to 2025-06-300USD91
2025-01-01 to 2025-06-300USD181
2024-04-01 to 2024-06-307,292USD91
2024-01-01 to 2024-06-307,292USD182

Nonoperating income or expense

Total nonoperating income or expense, which can include interest, investment results and other items. A positive value is not operating profit.

PeriodValueUnitDays
2025-04-01 to 2025-06-3049,123USD91
2025-01-01 to 2025-06-3096,642USD181
2024-04-01 to 2024-06-30-1,821USD91
2024-01-01 to 2024-06-3031,128USD182

Inspect the source

Entity
GEOVAX LABS, INC. / CIK 0000832489
Captured
2026-09-19T15:08:35.324Z
SEC response SHA-256
59a901b3497fda8a2be64a7de8bb7d8359e460cc8dc7a28f1eaf58764d360937

Current SEC company facts · Download the original response snapshot (gzip) · Download the selected JSON

Every published concept a filing tagged, with the periods it covered, as reported in that filing at capture time. Forms 10-K, 10-K/A, 10-Q, 10-Q/A, 20-F, 20-F/A, 40-F, 40-F/A. A filing page needs at least 8 published concepts. Later filings can restate these values; the company history pages show the latest-filed value per period.

Public company accounting reference, not market prices, returns, an investment recommendation, or ALPHAC performance. Validate a separately constructed return series with the validation API; accounting values are not returns.

Use this in research

A financial period ends before its results become public. Use the filing date as a minimum availability boundary, inspect amendments, and retain the original filing vintage when testing historical signals. This latest-filed selection can contain information unavailable at the time.

These pages do not supply prices, total-return histories, corporate-action adjustments or a tradable universe. Build those inputs separately before evaluating a strategy. A profitable backtest can still reflect selection bias or costs that were left out.

Research methodology · Execution and cost assumptions · Check backtest overfitting

Build with the open-source tools

Use these accounting records as inspectable inputs. When you have constructed a return series, the validation tools can help test its statistical evidence and preserve the result with its limitations.

Read the published dataset with Python
import json
from urllib.request import urlopen

with urlopen("https://canlicapital.com/company-data/0000832489.json") as response:
    record = json.load(response)
print(record["fetched_at"])
print(record["policy"])
for concept in record["concepts"]:
    print(concept["tag"], next(iter(concept["observations"])))